RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1998; 80(02): 351
DOI: 10.1055/s-0037-1615208
DOI: 10.1055/s-0037-1615208
Letters to the Editor
Human Parvovirus B19 Infection in Persons with Haemophilia
Autoren
Weitere Informationen
Publikationsverlauf
Received
10. Februar 1998
Accepted
09. April 1998
Publikationsdatum:
08. Dezember 2017 (online)
-
References
- 1 Aygören-Pürsün E, Scharrer I. German Kogenate Study Group.. A multicentre pharmacosurveillance study for the evaluation of the efficacy and safety of recombinant Factor VIII in the treatment of patients with haemophilia A.. Thromb Haemost 1998; 78: 1352-6.
- 2 Prowse CV. Parvovirus B19 and blood products.. Lancet 1994; 343: 1101.
- 3 Prowse CV, Ludlam CA, Yap PL. Human parvovirus B19 and blood products.. Vox Sang, 1998; 72: 1-10.
- 4 Prowse CV, Dow B, Pelly J. et al. Studies on B19 parvovirus in the normal and haemophilic. Scottish population in 1995.. Thromb Haemost 1998; Suppl: 455 (PS-1857).
- 5 Williams MD, Cohen BJ, Beddall AC, Pasi RJ, Mortimer P, Hill FGW. Transmission of human parvovirus B19 by coagulation factor concentrates.. Vox Sang 1990; 58: 177-81.